251
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Comparison of the interferon- γ release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers

, , , , , & show all
Pages 373-380 | Received 04 Jul 2007, Published online: 08 Jul 2009

References

  • Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007; 11: 593–605
  • Ong A, Rudoy I, Gonzalez LC, Creasman J, Kawamura LM, Daley CL. Tuberculosis in health care workers: a molecular epidemiological study in San Francisco. Infect Control Hosp Epidemiol 2006; 27: 453–8
  • Kantor HS, Poblete R, Pusateri SL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988; 84: 833–8
  • Tam CM, Leung CC. Occupational tuberculosis: a review of the literature and the local situation. Hong Kong Med J 2006; 12: 448–55
  • Alonso-Echanove J, Granich RM, Laszlo A, Chu G, Borja N, Blas R, et al. Occupational transmission of Mycobacterium tuberculosis to health care workers in a university hospital in Lima, Peru. Clin Infect Dis 2001; 33: 589–96
  • Beck-Sague C, Dooley SW, Hutton MD, Otten J, Breeden A, Crawford JT, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA 1992; 268: 1280–6
  • Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health care workers in low- and middle-income countries: a systematic review. PLoS Med 2006; 3: 494
  • Center for Disease Control DoH, Executive Yuan. Center for Disease Control, Taiwan, Annual Report 2006.: Center for Disease Control, Department of Health, Executive Yuan 2006.
  • Yu MC, Suo J, Huang C, Bai KJ, Lin TP, Luh KT. Annual risk of tuberculous infection in Taiwan, 1996–1998. J Formos Med Assoc 1999; 98: 496–9
  • Nosocomial transmission of Mycobacterium tuberculosis found through screening for severe acute respiratory syndrome–Taipei, Taiwan, 2003. MMWR Morb Mortal Wkly Rep 2004;53:321–2.
  • Guidelines for Nosocomial Tuberculosis Infection Control. Taipei: Centers for Disease Control, Department of Health, Executive Yuan, 2004.
  • Guidelines for Diagnosis and Treatment of Tuberculosis. Taipei: Centers of Disease Control, Department of Health, Executive Yuan, 2006.
  • Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999; 159: 15–21
  • Yeh YP, Luh DL, Chang SH, Suo J, Chang HJ, Chen TH. Tuberculin reactivity in adults after 50 years of universal Bacille Calmette-Guerin vaccination in Taiwan. Trans R Soc Trop Med Hyg 2005; 99: 509–16
  • Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340–54
  • Pai M, Riley LW, Colford JM, Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761–76
  • Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole blood interferon-gamma and Mantoux testing among Japanese health care workers. Infect Control Hosp Epidemiol 2006; 27: 442–8
  • Brock I, Munk ME, Kok-Jensen A, Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001; 5: 462–7
  • Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004; 170: 59–64
  • Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000;161:S221–47.
  • Jensen PA Lambert LA Iademarco MF Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care settings, 2005. MMWR Recomm Rep 2005;54:1–141.
  • Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363–74
  • Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006; 174: 349–55
  • Statistics of Communicable Diseases and Surveillance Report, Republic of China, 2005. Taipei: Centers for Disease Control, Department of Health, Executive Yuan, 2006.
  • Farhat M, Greenaway C, Pai M, Menzies D. False positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?. Int J Tuberc Lung Dis 2006; 10: 1192–204
  • Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette-Guerin vaccination on tuberculin skin test measurements. Thorax 2002; 57: 804–9
  • Moreno S, Blazquez R, Novoa A, Carpena I, Menasalvas A, Ramirez C, et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med 2001; 161: 1760–5
  • Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of Bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?. Clin Infect Dis 2005; 40: 211–7
  • Mckay A, Kraut A, Murdzak C, Yassi A. Determinants of tuberculin reactivity among health care workers: interpretation of positivity following BCG vaccination. Can J Infect Dis Med Microbiol 1999; 10: 134–9
  • Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007; 11: 1–196
  • Control and prevention of tuberculosis in the United Kingdom: code of practice (2000) 2000. Joint Tuberculosis Committee of the British Thoracic Society. Thorax ;55:887–901.
  • Menzies D. What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us?. Clin Infect Dis 2000; 31(Suppl 3)S71–4
  • Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the whole blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756–61
  • Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 2006; 7: 77
  • Pai M, Menzies D. The new IGRA and the old TST: making good use of disagreement. Am J Respir Crit Care Med 2007; 175: 529–31
  • Pai M, Kalantri S, Menzies D. Discordance between tuberculin skin test and interferon-gamma assays. Int J Tuberc Lung Dis 2006; 10: 942–3
  • Mahomed H, Hughes EJ, Hawkridge T, Minnies D, Simon E, Little F, et al. Comparison of Mantoux skin test with 3 generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10: 310–6
  • Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746–55
  • Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003; 52: 15–8
  • Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170: 65–9
  • Ravn P, Munk ME, Andersen AB, Lundgren B, Lundgren JD, Nielsen LN, et al. Prospective evaluation of a whole blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005; 12: 491–6
  • Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631–5
  • Porsa E, Cheng L, Seale MM, Delclos GL, Ma X, Reich R, et al. Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol 2006; 13: 53–8
  • Arend SM, Thijsen SF, Leyten EM, Bouwman JJ, Franken WP, Koster BF, et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175: 618–27
  • Sepulveda RL, Ferrer X, Latrach C, Sorensen RU. The influence of Bacille Calmette-Guerin immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990; 142: 24–8
  • Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26: 28–106
  • Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T-cell assay conversions and reversions?. PLoS Med 2007; 4: 208

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.